increased heart rate with glp 1 GLP-1 Agonists and JCI - Cardioprotective GLP-1 metabolite
Description
Both had a similar average weight loss at the end of the trial (14.9% for Wegovy vs 15% for Mounjaro), and both had a similar amount of participants who achieved at least a 5% decrease in body weight (86.4% for Wegovy vs 85% for Mounjaro)
If test results are normal, repeat testing at a minimum of three-year intervals is reasonable
Have a medical-related question you've always wanted answered
No upsells
You may be looking for a gentle way to support your metabolism, improve your rest, or curb late-night snacking
